p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents - PubMed (original) (raw)
. 1994 Nov 15;54(22):5824-30.
Affiliations
- PMID: 7954409
p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents
S Fan et al. Cancer Res. 1994.
Abstract
The present study assessed the role of the p53 tumor suppressor gene in cell cycle arrest and apoptosis following treatment of Burkitt's lymphoma and lymphoblastoid cell lines with gamma-rays, etoposide, nitrogen mustard, and cisplatin. Cell cycle arrest was measured by flow cytometry; p53 and p21Waf1/Cip1 protein levels were measured by Western blotting; cell survival was measured in 72-96-h growth inhibition assays and by trypan blue staining, and apoptotic DNA fragmentation was assessed by either agarose gel electrophoresis or a modified filter elution method. We found that gamma-rays and etoposide induced a strong G1 arrest in the wild-type p53 lines while nitrogen mustard and cisplatin induced relatively little G1 arrest. All agents failed to induce G1 arrest in cells containing mutant p53 genes. The degree of G1 arrest observed with these agents correlated with the rate of p53 and p21Waf1/Cip1 protein accumulation: gamma-rays and etoposide induced rapid accumulation of both p53 and p21Waf1/Cip1; nitrogen mustard and cisplatin induced slow accumulation of p53 and no major accumulation of the p21Waf1/Cip1 protein. Despite differences in G1 arrest and kinetics of p53 or p21Waf1/Cip1 protein accumulation, all agents tended to decrease survival to a greater extent in the wild-type p53 lines compared to the mutant p53 lines. Cell death in the wild-type p53 lines was associated with intracellular DNA degradation into oligonucleosomal sized DNA fragments, indicative of apoptosis. We also observed an inverse sensitivity relationship between nitrogen mustard/cisplatin and etoposide in the mutant p53 lines and this was found to correlate with topoisomerase II mRNA levels in the cells. Our results suggest that p53 gene status is an important determinant of both radio- and chemosensitivity in lymphoid cell lines and that p53 mutations are often associated with decreased sensitivity to DNA damaging agents.
Similar articles
- Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
Delia D, Goi K, Mizutani S, Yamada T, Aiello A, Fontanella E, Lamorte G, Iwata S, Ishioka C, Krajewski S, Reed JC, Pierotti MA. Delia D, et al. Oncogene. 1997 May 8;14(18):2137-47. doi: 10.1038/sj.onc.1201050. Oncogene. 1997. PMID: 9174049 - p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
Kagawa S, Fujiwara T, Hizuta A, Yasuda T, Zhang WW, Roth JA, Tanaka N. Kagawa S, et al. Oncogene. 1997 Oct 16;15(16):1903-9. doi: 10.1038/sj.onc.1201362. Oncogene. 1997. PMID: 9365236 - Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines.
O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I, Kohn KW. O'Connor PM, et al. Cancer Res. 1993 Oct 15;53(20):4776-80. Cancer Res. 1993. PMID: 8402660 - [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F, Bay JO, Dionet C, Verrelle P. Teyssier F, et al. Bull Cancer. 1999 Apr;86(4):345-57. Bull Cancer. 1999. PMID: 10341340 Review. French. - Marker genes for cytotoxic exposure: p53.
Montenarh M. Montenarh M. Stem Cells. 1995 May;13 Suppl 1:136-41. Stem Cells. 1995. PMID: 7488939 Review.
Cited by
- Metal-Based Anticancer Complexes and p53: How Much Do We Know?
Alfadul SM, Matnurov EM, Varakutin AE, Babak MV. Alfadul SM, et al. Cancers (Basel). 2023 May 19;15(10):2834. doi: 10.3390/cancers15102834. Cancers (Basel). 2023. PMID: 37345171 Free PMC article. Review. - Effectiveness of Nonfunctionalized Graphene Oxide Nanolayers as Nanomedicine against Colon, Cervical, and Breast Cancer Cells.
Hatshan MR, Saquib Q, Siddiqui MA, Faisal M, Ahmad J, Al-Khedhairy AA, Shaik MR, Khan M, Wahab R, Matteis V, Adil SF. Hatshan MR, et al. Int J Mol Sci. 2023 May 23;24(11):9141. doi: 10.3390/ijms24119141. Int J Mol Sci. 2023. PMID: 37298090 Free PMC article. - RUNX2 Reverses p53-Induced Chemotherapy Resistance in Gastric Cancer.
Huang Y, Liang L, Zhao YX, Yao BH, Zhang RM, Song L, Zhang ZT. Huang Y, et al. Pharmgenomics Pers Med. 2023 Mar 27;16:253-261. doi: 10.2147/PGPM.S394393. eCollection 2023. Pharmgenomics Pers Med. 2023. PMID: 37009416 Free PMC article. - Application of Monolayer Cell Cultures for Investigating Basic Mechanisms of Photodynamic Therapy.
Broekgaarden M. Broekgaarden M. Methods Mol Biol. 2022;2451:3-20. doi: 10.1007/978-1-0716-2099-1_1. Methods Mol Biol. 2022. PMID: 35505006 - TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer Cell.
Lei G, Liu S, Yang X, He C. Lei G, et al. Can J Gastroenterol Hepatol. 2021 Mar 22;2021:8870907. doi: 10.1155/2021/8870907. eCollection 2021. Can J Gastroenterol Hepatol. 2021. PMID: 33824865 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous